Atlas Trials

Human Metapneumovirus Immunization

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Human Metapneumovirus Immunization

RecordFirmDate
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older (NCT07734649)Sanofi2026-07-22
Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older (NCT06686654)Sanofi Pasteur, a Sanofi Company2024-11-11

Track Human Metapneumovirus Immunization automatically

Every clearance here is in the API, with alerts when new ones post.